Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AG, age, Alabama, allergy, AngioSense, anti, auto, autoimmune, bacteria, behalf, Belt, biomolecular, Black, Bulletin, Calorimetry, capillary, choose, clarification, cloud, Codification, commonly, constituent, contemplation, correlating, DBS, Delhi, Department, dermatology, diagnosing, disaggregate, discovering, DiscoveryTM, dose, drag, easily, ELISA, empowering, endocrinology, Euribor, euroimmun, EUROLINETM, exploration, explore, explorer, Fabry, fight, fill, filter, FolateRSense, formally, frequency, gastroenterology, gathering, Gaucher, Genpact, GILTI, guided, headspace, Helsinki, hepatology, HyperDSCTM, IFT, immunosorbent, immunotesting, inappropriate, injection, injector, IntegriSense, interpretation, Interpretive, investee, ionization, Krabbe, Labordiagnostika, land, leader, lean, Lehigh, lengthy, lightweight, Lubeck, LuminaTM, mandatory, marked, matrix, meat, Medizinische, methodology, MMPSense, MultiPrep, NENTM, NeoLSDTM, nephrology, neurology, NEXTFLEX, NextPrep, Nightingale, Nivo, nonrecurring, NumberTM, OsteoSense, Oy, paired, partly, PCAOB, PCR, perfunctory, pinpoint, PolarisTM, Pompe, popular, ProSense, purport, radio, reach, RediJect, reform, repaid, ReviewTM, rheumatology, RNA, robust, routine, running, SEC, ServiceTM, setup, Shingijitsu, Sigma, SignalsTM, simplicity, situ, smarter, SPME, sterling, store, submission, Suzhou, SymbioTM, Tajinder, territorial, TGA, title, tomography, TouchTM, TRF, UHPLC, unaudited, unique, VanadisTM, Varex, versatile, vertical, Vohra, withdraw, withdrawal, withdrawing, XenoLightTM
Removed:
acid, Affymetrix, amplified, analytically, automation, beam, Biochem, BL, breached, bring, broken, building, cassette, CellCarrier, collusion, complaint, cone, consumable, contaminant, coregistered, CT, dental, detected, device, Dexela, distributorship, EnSpire, Enzo, experimental, exploitation, film, GX, hit, immunology, improper, infringed, inspection, intelligence, Internet, iPad, library, lung, moved, multilabel, multiplex, NEN, nucleic, organization, override, panel, PCB, pipeline, powered, proper, quantitation, radiography, reallocated, resolve, rich, scan, scanner, scientifically, silicon, spectrometer, staining, supporting, therapy, Touch, treatment, trial, TRIO, unfair, upgrade, varied, XRD, XRpad
Filing tables
Filing exhibits
- 10-K Annual report
- 2.5 Amendment Agreement to the Share Sale and Transfer Agreement Dated June 26, 2017
- 10.27 Perkinelmer, Inc. Global Incentive Compensation Plan (Executive Officers)
- 12.1 Statement Regarding Computation of Ratio of Earnings to Fixed Charges
- 21 Subsidiaries of Perkinelmer, Inc.
- 23 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of CEO Pursuant to Section 302
- 31.2 Certification of CFO Pursuant to Section 302
- 32.1 Certification of CEO and CFO Pursuant to Section 906
- Download Excel data file
- View Excel data file
Related press release
Associated RVTY transcripts
RVTY similar filings
Filing view
External links
EXHIBIT 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-61615, 333-65367, 333-81759, 333-61938, 333-73350, 333-92228, 333-129407 and 333-158877 on Form S-8 and 333-210279 on Form S-3 of our reports dated February 27, 2018, relating to the financial statements and financial statement schedule of PerkinElmer, Inc. and subsidiaries, and the effectiveness of PerkinElmer, Inc. and subsidiaries' internal control over financial reporting, appearing in this Annual Report on Form 10-K of PerkinElmer, Inc. for the year ended December 31, 2017.
/s/ DELOITTE & TOUCHE LLP |
Boston, Massachusetts |
February 27, 2018 |